Biotech · Private company
miRagen Therapeutics, Inc.
Track this companyFree. Adds miRagen Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- CobomarsenPhase 2 · Cutaneous T-Cell Lymphoma/Mycosis FungoidesClinicalTrials.gov · fetched Nov 12, 2026
- RemlarsenPhase 2 · KeloidClinicalTrials.gov · fetched Nov 12, 2026
- VorinostatPhase 2 · Cutaneous T-Cell Lymphoma/Mycosis FungoidesClinicalTrials.gov · fetched Nov 12, 2026
- CobomarsenPhase 1 · Cutaneous T-cell Lymphoma (CTCL)ClinicalTrials.gov · fetched Nov 12, 2026
- MRG-110Phase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- PRISM: Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Mycosis Fungoides Who Have Completed the SOLAR StudyPHASE2 · TERMINATED · started Oct 1, 2019ClinicalTrials.gov NCT03837457 · fetched Nov 12, 2026
- SOLAR: Efficacy and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects With Mycosis FungoidesPHASE2 · TERMINATED · started Apr 2, 2019ClinicalTrials.gov NCT03713320 · fetched Nov 12, 2026
- Efficacy, Safety, and Tolerability of Remlarsen (MRG-201) Following Intradermal Injection in Subjects With a History of KeloidsPHASE2 · COMPLETED · started Jun 11, 2018ClinicalTrials.gov NCT03601052 · fetched Nov 12, 2026
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MRG-110 Following Intradermal Injection in Healthy VolunteersPHASE1 · COMPLETED · started Apr 9, 2018ClinicalTrials.gov NCT03603431 · fetched Nov 12, 2026
- Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLLPHASE1 · COMPLETED · started Feb 9, 2016ClinicalTrials.gov NCT02580552 · fetched Nov 12, 2026